SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-17-000028
Filing Date
2017-08-09
Accepted
2017-08-09 17:21:55
Documents
94
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20170630x10q.htm 10-Q 2682819
2 EX-10.1 amph-20170630ex10194bf0e.htm EX-10.1 289234
3 EX-10.2 amph-20170630ex1023a173f.htm EX-10.2 941617
4 EX-10.3 amph-20170630ex103f33d2a.htm EX-10.3 126634
5 EX-10.4 amph-20170630ex104d72f99.htm EX-10.4 798950
6 EX-31.1 amph-20170630ex3111a243d.htm EX-31.1 22856
7 EX-31.2 amph-20170630ex312186ef5.htm EX-31.2 22982
8 EX-32.1 amph-20170630ex321b4df1c.htm EX-32.1 12339
9 EX-32.2 amph-20170630ex322a887c6.htm EX-32.2 12312
  Complete submission text file 0001297184-17-000028.txt   13438013

Data Files

Seq Description Document Type Size
10 EX-101.INS amph-20170630.xml EX-101.INS 2846577
11 EX-101.SCH amph-20170630.xsd EX-101.SCH 72262
12 EX-101.CAL amph-20170630_cal.xml EX-101.CAL 56648
13 EX-101.DEF amph-20170630_def.xml EX-101.DEF 256630
14 EX-101.LAB amph-20170630_lab.xml EX-101.LAB 515661
15 EX-101.PRE amph-20170630_pre.xml EX-101.PRE 459619
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 171018952
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences